Nuclear Medicine: Page 284

Bayer, AC Immune join forces

By AuntMinnie.com staff writers

German pharmaceutical firm Bayer Schering Pharma is providing its florbetaben PET tracer to Swiss biopharmaceutical company AC Immune for an Alzheimer's disease clinical trial.

October 8, 2009

FDG-PET uptake helps predict vascular events in cancer patients

By Wayne Forrest

German researchers have discovered that FDG uptake in major arteries is the "strongest predictor of a subsequent vascular event" in cancer patients, with severe calcification also indicating high risk, according to an article published in the October issue of the Journal of Nuclear Medicine.

October 8, 2009

Philips develops silicon photomultiplier technology

By AuntMinnie.com staff writers

Philips Healthcare parent Royal Philips Electronics said it has developed a digital silicon photomultiplier technology that it believes will allow for faster and more accurate photon counting in applications such as PET imaging.

October 7, 2009

Fowler to receive Nat'l Medal of Science

By AuntMinnie.com staff writers

Joanna Fowler, Ph.D., a major contributor to brain research and a pioneer in molecular imaging, was scheduled to receive the National Medal of Science at the White House on Wednesday.

October 6, 2009

Siemens launches cardiac imaging software

By AuntMinnie.com staff writers

Siemens Healthcare has released syngo Dynamic PET with Myocardial Blood Flow, a new cardiac imaging software application for the company's Biograph PET/CT scanners.

October 5, 2009

CMS reissues FDG-PET guidelines

By AuntMinnie.com staff writers

The U.S. Centers for Medicare and Medicaid Services (CMS) has reissued its guidance and billing instructions for the April 2009 changes to the National Coverage Determination on FDG-PET.

October 5, 2009